Christy Sandborg

Professor of Pediatrics (Rheumatology) at the Lucile Salter Packard Children's Hospital

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1984)

Residency: Children's Hospital Los Angeles (1979) CA

Board Certification: Pediatric Rheumatology, American Board of Pediatrics (1992)

Fellowship: Children's Hospital (1981) CA

Medical Education: UCLA School of Medicine (1977) CA

MD, UCLA, Medicine (1977)

Administrative Appointments

Vice President of Medical Affairs, Lucile Packard Children's Hospital at Stanford (2012 - Present)

Associate Chair, Department of Pediatrics (2008 - Present)

Chief of Staff, Lucile Packard Children's Hospital at Stanford (2008 - 2012)

Co-Director, Spectrum Child Health, Lucile Packard Children's Hospital and Stanford School of Medicine (2005 - Present)

Immediate Past Chair, Childhood Arthritis and Rheumatology Research Alliance (CARRA), Stanford (2007 - 2010)

Chief of Pediatric Rheumatology, Stanford (1997 - 2012)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

A167: variations in patterns of care across pediatric rheumatic diseases in the childhood arthritis & rheumatology alliance network registry.
Natter, M. D., Ong, M.-S., Ilowite, N. T., Mandl, K. D., Mieszkalski, K. L., & Schanberg, L. E. (2014). A167: variations in patterns of care across pediatric rheumatic diseases in the childhood arthritis & rheumatology alliance network registry. Arthritis & rheumatology (Hoboken, N.J.), 66, S215-6.

Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
Ardoin, S. P., Schanberg, L. E., Sandborg, C. I., Barnhart, H. X., Evans, G. W., & Thompson, S. D. (2014). Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. ANNALS OF THE RHEUMATIC DISEASES, 73(3), 557-566.

Shrinking Lung Syndrome as a Manifestation of Pleuritis: A New Model Based on Pulmonary Physiological Studies
Henderson, L. A., Loring, S. H., Gill, R. R., Liao, K. P., Ishizawar, R., & Nigrovic, P. A. (2013). Shrinking Lung Syndrome as a Manifestation of Pleuritis: A New Model Based on Pulmonary Physiological Studies. JOURNAL OF RHEUMATOLOGY, 40(3), 273-281.

An i2b2-based, generalizable, open source, self-scaling chronic disease registry
Natter, M. D., Quan, J., Ortiz, D. M., Bousvaros, A., Ilowite, N. T., & Mandl, K. D. (2013). An i2b2-based, generalizable, open source, self-scaling chronic disease registry. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 20(1), 172-179.

A New Era in the Treatment of Systemic Juvenile Idiopathic Arthritis
Sandborg, C., & Mellins, E. D. (2012). A New Era in the Treatment of Systemic Juvenile Idiopathic Arthritis. NEW ENGLAND JOURNAL OF MEDICINE, 367(25), 2439-2440.

Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis
Ling, X. B., Macaubas, C., Alexander, H. C., Wen, Q., Chen, E., & Mellins, E. D. (2012). Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis. BMC MEDICINE, 10.

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
Ilowite, N. T., Sandborg, C. I., Feldman, B. M., Grom, A., Schanberg, L. E., & Zemel, L. (2012). Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. PEDIATRIC RHEUMATOLOGY, 10.

European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort
Frankovich, J. D., Hsu, J. J., & Sandborg, C. I. (2012). European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort. LUPUS, 21(4), 421-429.

Use of atorvastatin in systemic lupus erythematosus in children and adolescents
Schanberg, L. E., Sandborg, C., Barnhart, H. X., Ardoin, S. P., Yow, E., & Thompson, S. D. (2012). Use of atorvastatin in systemic lupus erythematosus in children and adolescents. ARTHRITIS AND RHEUMATISM, 64(1), 285-296.

The Childhood Arthritis & Rheumatology Research Alliance Network Registry: Demographics and Characteristics of the Initial One Year Cohort
Natter, M. D., Winsor, J. R., Fox, K. A., Ilowite, N. T., Mandl, K. D., & Schanberg, L. E. (2011). The Childhood Arthritis & Rheumatology Research Alliance Network Registry: Demographics and Characteristics of the Initial One Year Cohort. ARTHRITIS AND RHEUMATISM, 63(10), S291-S292.

Implementing an Interoperable Personal Health Record in Pediatrics: Lessons Learned at an Academic Children's Hospital.
Anoshiravani, A., Gaskin, G., Kopetsky, E., Sandborg, C., & Longhurst, C. A. (2011). Implementing an Interoperable Personal Health Record in Pediatrics: Lessons Learned at an Academic Children's Hospital. Journal of participatory medicine, 3.

Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications
Ling, X. B., Park, J. L., Carroll, T., Nguyen, K. D., Lau, K., & Mellins, E. D. (2010). Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. PROTEOMICS, 10(24), 4415-4430.

Behcet's disease and heart transplantation: A word of caution
Hollander, S. A., Yasnovsky, J. R., Reinhartz, O., Chan, F., Sandborg, C., & Chin, C. (2010). Behcet's disease and heart transplantation: A word of caution. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(11), 1306-1308.

Living Profiles: Design of a health media platform for teens with special healthcare needs
Chira, P., Nugent, L., Miller, K., Park, T., Donahue, S., & Sandborg, C. (2010). Living Profiles: Design of a health media platform for teens with special healthcare needs. JOURNAL OF BIOMEDICAL INFORMATICS, 43(5), S9-S12.

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort
Ardoin, S. P., Schanberg, L. E., Sandborg, C., Yow, E., Barnhart, H. X., & Reed, A. M. (2010). Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. LUPUS, 19(11), 1315-1325.

Decrease in Hospital-wide Mortality Rate After Implementation of a Commercially Sold Computerized Physician Order Entry System
Longhurst, C. A., Parast, L., Sandborg, C. I., Widen, E., Sullivan, J., & Sharek, P. J. (2010). Decrease in Hospital-wide Mortality Rate After Implementation of a Commercially Sold Computerized Physician Order Entry System. PEDIATRICS, 126(1), 14-21.

PEDIATRIC RHEUMATIC DISEASE Standards of care for JIA-the basic foundation for quality
Sandborg, C. (2010). PEDIATRIC RHEUMATIC DISEASE Standards of care for JIA-the basic foundation for quality. NATURE REVIEWS RHEUMATOLOGY, 6(7), 389-390.

Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states
Macaubas, C., Nguyen, K., Deshpande, C., Phillips, C., Peck, A., & Mellins, E. D. (2010). Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. CLINICAL IMMUNOLOGY, 134(2), 206-216.

Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus
Schanberg, L. E., Sandborg, C., Barnhart, H. X., Ardoin, S. P., Yow, E., & Reed, A. (2009). Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus. ARTHRITIS AND RHEUMATISM, 60(5), 1496-1507.

Consensus development of a corticosteroid (CS) tapering algorithm for the randomized placebo phase study of rilonocept in the treatment of systemic JIA (RAPPORT)
Sandborg, C., Giannini, E. H., Feldman, B. M., GOTTLIEB, B., Grom, A., & Ilowite, N. (2008). Consensus development of a corticosteroid (CS) tapering algorithm for the randomized placebo phase study of rilonocept in the treatment of systemic JIA (RAPPORT). ARTHRITIS AND RHEUMATISM, 58(9), S248-S249.

Clinical laboratory markers of cardiovascular risk in a pediatric SLE cohort
Ardoin, S., Schanberg, L., Bamhart, H., Yow, E., Mieszkalski, K., & Sandborg, C. (2008). Clinical laboratory markers of cardiovascular risk in a pediatric SLE cohort. ARTHRITIS AND RHEUMATISM, 58(9), S252-S253.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Lovell, D. J., Ruperto, N., Goodman, S., Reiff, A., Jung, L., & Martini, A. (2008). Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. NEW ENGLAND JOURNAL OF MEDICINE, 359(8), 810-820.

Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus
Sandborg, C., Ardoin, S. P., & Schanberg, L. (2008). Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 4(5), 258-265.

Reduced levels of FasL and apoptosis resistance in SJIA monocytes
Srivastava, S., Macaubas, C., Lee, T., Sandborg, C., & Mellins, E. (2008). Reduced levels of FasL and apoptosis resistance in SJIA monocytes. CLINICAL IMMUNOLOGY, 127, S93-S93.

Predictors of increased carotid intima media thickness (CIMT) in the atherosclerosis prevention in pediatric lupus erythernatosus (APPLE) cohort
Schanberg, L. E., Sandborg, C., Ardoin, S. P., Mieszkalski, K. L., Yow, E., & Barnhart, H. (2007). Predictors of increased carotid intima media thickness (CIMT) in the atherosclerosis prevention in pediatric lupus erythernatosus (APPLE) cohort. ARTHRITIS AND RHEUMATISM, 56(12), 4235-4235.

Distinct molecular and cellular aspects of systemic juvenile idiopathic arthritis (SJIA) and polyarticular (PolyJIA)
Macaubas, C., Nguyen, K., Pan, K.-H., Lee, T., Deshpande, C., & Mellins, E. (2007). Distinct molecular and cellular aspects of systemic juvenile idiopathic arthritis (SJIA) and polyarticular (PolyJIA). CLINICAL IMMUNOLOGY, 123, S94-S95.

Management of dyslipidemia in children and adolescents with systemic lupus erythematosus
Ardoin, S. P., Sandborg, C., & Schanberg, L. E. (2007). Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. LUPUS, 16(8), 618-626.

Availability of pediatric rheumatology training in United States pediatric residencies.
Mayer, M. L., Brogan, L., & Sandborg, C. I. (2006). Availability of pediatric rheumatology training in United States pediatric residencies. Arthritis and rheumatism, 55(6), 836-842.

Rafting the ethical rapids.
Collier, J., Rorty, M., & Sandborg, C. (2006). Rafting the ethical rapids. HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues, 18(4), 332-341.

Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis
Sandborg, C., Holmes, T. H., Lee, T., Biederman, K., Bloch, D. A., & Mellins, E. D. (2006). Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. JOURNAL OF RHEUMATOLOGY, 33(11), 2322-2329.

Systemic hyalinosis: A distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2)
Shieh, J. Tc., Swidler, P., Martignetti, J. A., Ramirez, M. C. M., Balboni, I., & Hoyme, H. E. (2006). Systemic hyalinosis: A distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2). PEDIATRICS, 118(5), E1485-E1492.

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies
Harel, L., Sandborg, C., Lee, T., & von Scheven, E. (2006). Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. JOURNAL OF RHEUMATOLOGY, 33(9), 1873-1877.

Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
Ward, M. M., Bruckel, J., Colbert, R., Doedhar, A., Emerson, C., & Davis, J. C. (2006). Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). journal of rheumatology, 33(5), 978-982.

The future of rheumatology research: the Childhood Arthritis and Rheumatology Research Alliance.
Sandborg, C. (2006). The future of rheumatology research: the Childhood Arthritis and Rheumatology Research Alliance. Current problems in pediatric and adolescent health care, 36(3), 104-109.

Differential expression of immune parameters in systemic juvenile idiopathic arthritis (SJIA) flare and quiescence.
Nguyen, K., Macaubas, C., Deshpande, C., Lee, T., Sandborg, C., & Mellins, E. (2006). Differential expression of immune parameters in systemic juvenile idiopathic arthritis (SJIA) flare and quiescence. CLINICAL IMMUNOLOGY, 119, S72-S72.

History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry
Pachman, L. M., Lipton, R., Ramsey-Goldman, R., Shamiyeh, E., Abbott, K., & Borzy, M. (2005). History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 53(2), 166-172.

The first step: DNAR outside the hospital and the role of pediatric medical care providers
Collier, J., & Sandborg, C. (2005). The first step: DNAR outside the hospital and the role of pediatric medical care providers. AMERICAN JOURNAL OF BIOETHICS, 5(1), 85-86.

Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus.
Schanberg, L. E., & Sandborg, C. (2004). Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus. Current rheumatology reports, 6(6), 425-433.

Adolescent rheumatology transitional care: steps to bringing health policy into practice
Chira, P., & Sandborg, C. (2004). Adolescent rheumatology transitional care: steps to bringing health policy into practice. RHEUMATOLOGY, 43(6), 687-689.

Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection
Hsu, D., Sandborg, C., & Hahn, J. S. (2004). Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection. JOURNAL OF CHILD NEUROLOGY, 19(4), 304-306.

Role of pediatric and internist rheumatologists in treating children with rheumatic diseases
Mayer, M. L., Sandborg, C. I., & Mellins, E. D. (2004). Role of pediatric and internist rheumatologists in treating children with rheumatic diseases. PEDIATRICS, 113(3), E173-E181.

Access to pediatric rheumatology care in the United States
Mayer, M. L., Mellins, E. D., & Sandborg, C. I. (2003). Access to pediatric rheumatology care in the United States. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 49(6), 759-765.

Novel therapies in pediatric rheumatic diseases
Chira, P., & Sandborg, C. I. (2003). Novel therapies in pediatric rheumatic diseases. CURRENT OPINION IN PEDIATRICS, 15(6), 579-585.

Growth delay in systemic JRA: Interplay between steroid usage and disease severity
Lee, T., Sandborg, C., Biederman, K., & Mellins, E. (2002). Growth delay in systemic JRA: Interplay between steroid usage and disease severity. ARTHRITIS AND RHEUMATISM, 46(12), 3405-3405.

Magnetic resonance imaging in the diagnosis and follow up of Takayasu's arteritis in children
Aluquin, V. Pr., Albano, S. A., Chan, F., Sandborg, C., & Pitlick, P. T. (2002). Magnetic resonance imaging in the diagnosis and follow up of Takayasu's arteritis in children. ANNALS OF THE RHEUMATIC DISEASES, 61(6), 526-529.

Expression of autoimmunity in the transition from childhood to adulthood: Role of cytokines and gender
Sandborg, C. (2002). Expression of autoimmunity in the transition from childhood to adulthood: Role of cytokines and gender. JOURNAL OF ADOLESCENT HEALTH, 30(4), 76-80.

Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies
Olson, J. A., Olson, D. M., Sandborg, C., Alexander, S., & Buckingham, B. (2002). Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. PEDIATRICS, 109(3).

Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents
Lee, T., von Scheven, E., & Sandborg, C. (2001). Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. CURRENT OPINION IN RHEUMATOLOGY, 13(5), 415-421.

Development of systemic lupus erythematosus following autologous bone marrow transplant for acute lymphocytic leukemia
Steinbach, W. J., & Sandborg, C. I. (2001). Development of systemic lupus erythematosus following autologous bone marrow transplant for acute lymphocytic leukemia. JOURNAL OF RHEUMATOLOGY, 28(6), 1467-1468.

A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus
Buckingham, B. A., & Sandborg, C. I. (2000). A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. CLINICAL IMMUNOLOGY, 96(2), 86-90.

Position statement of the American college of rheumatology regarding referral of children and adolescents to pediatric rheumatologists
Sandborg, C. I., & Wallace, C. A. (1999). Position statement of the American college of rheumatology regarding referral of children and adolescents to pediatric rheumatologists. ARTHRITIS CARE AND RESEARCH, 12(1), 48-51.

Progressive multifocal leukoencephalopathy in a 15-year-old boy with scleroderma and secondary amyloidosis
Hahn, J. S., Harris, B. T., Gutierrez, K., & Sandborg, C. (1998). Progressive multifocal leukoencephalopathy in a 15-year-old boy with scleroderma and secondary amyloidosis. PEDIATRICS, 102(6), 1475-1479.

Childhood systemic lupus erythematosus and neonatal lupus syndrome.
Sandborg, C. I. (1998). Childhood systemic lupus erythematosus and neonatal lupus syndrome. Current opinion in rheumatology, 10(5), 481-487.

Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
Berman, M. A., Sandborg, C. I., Wang, Z. S., Imfeld, K. L., Zaldivar, F., & Buckingham, B. A. (1996). Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. JOURNAL OF IMMUNOLOGY, 157(10), 4690-4696.

IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA
Sandborg, C. I., Imfeld, K. L., Zaldivar, F., Wang, Z. S., Buckingham, B. A., & Berman, M. A. (1995). IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA. JOURNAL OF IMMUNOLOGY, 155(11), 5206-5212.

HIV TYPE-1 INDUCTION OF INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION BY HUMAN THYMIC CELLS
Sandborg, C. I., Imfeld, K. L., Zaldivar, F., & Berman, M. A. (1994). HIV TYPE-1 INDUCTION OF INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION BY HUMAN THYMIC CELLS. AIDS RESEARCH AND HUMAN RETROVIRUSES, 10(10), 1221-1229.

HIV-1 INFECTION OF MACROPHAGES PROMOTES LONG-TERM SURVIVAL AND SUSTAINED-RELEASE OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-6
Berman, M. A., Zaldivar, F., Imfeld, K. L., Kenney, J. S., & Sandborg, C. I. (1994). HIV-1 INFECTION OF MACROPHAGES PROMOTES LONG-TERM SURVIVAL AND SUSTAINED-RELEASE OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-6. AIDS RESEARCH AND HUMAN RETROVIRUSES, 10(5), 529-539.

A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION
KAWAHARA, D. J., Everts, M., Buckingham, B., Sandborg, C., & Berman, M. (1991). A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION. JOURNAL OF IMMUNOTHERAPY, 10(3), 182-188.

INTERLEUKIN-1 AND A 7-KDA T-CELL INHIBITORY MONOKINE REFLECT DISEASE-ACTIVITY IN INFECTION WITH HIV-1
Sandborg, C. I., Berman, M. A., Imfeld, K. L., Cesario, T. C., & Zaldivar, F. (1990). INTERLEUKIN-1 AND A 7-KDA T-CELL INHIBITORY MONOKINE REFLECT DISEASE-ACTIVITY IN INFECTION WITH HIV-1. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 3(12), 1148-1154.

MODULATION OF IL-1-ALPHA, IL-1-BETA, AND 25K MR NON-IL-1 ACTIVITY RELEASED BY HUMAN MONONUCLEAR-CELLS
Sandborg, C. I., Berman, M. A., Imfeld, K. L., Zaldivar, F., MASADA, M. P., & Kenney, J. S. (1989). MODULATION OF IL-1-ALPHA, IL-1-BETA, AND 25K MR NON-IL-1 ACTIVITY RELEASED BY HUMAN MONONUCLEAR-CELLS. JOURNAL OF LEUKOCYTE BIOLOGY, 46(5), 417-427.

CHANGES IN CIRCULATING MONOCYTES IN PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS
Andrews, B. S., FRIOU, G. J., Berman, M. A., Sandborg, C. I., Mirick, G. R., & Cesario, T. C. (1987). CHANGES IN CIRCULATING MONOCYTES IN PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS. JOURNAL OF RHEUMATOLOGY, 14(5), 930-935.

INTERLEUKIN-1 INHIBITOR MASKS HIGH INTERLEUKIN-1 PRODUCTION IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)
Berman, M. A., Sandborg, C. I., CALABIA, B. S., Andrews, B. S., & FRIOU, G. J. (1987). INTERLEUKIN-1 INHIBITOR MASKS HIGH INTERLEUKIN-1 PRODUCTION IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS). CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 42(1), 133-140.

INCREASED PRODUCTION OF AN INTERLEUKIN-1 (IL-1) INHIBITOR WITH FIBROBLAST STIMULATING ACTIVITY BY MONONUCLEAR-CELLS FROM PATIENTS WITH SCLERODERMA
Sandborg, C. I., Berman, M. A., Andrews, B. S., Mirick, G. R., & FRIOU, G. J. (1986). INCREASED PRODUCTION OF AN INTERLEUKIN-1 (IL-1) INHIBITOR WITH FIBROBLAST STIMULATING ACTIVITY BY MONONUCLEAR-CELLS FROM PATIENTS WITH SCLERODERMA. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 66(2), 312-319.

SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS
Buckingham, B., PEREJDA, A. J., Sandborg, C., KERSHNAR, A. K., & UITTO, J. (1986). SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 140(5), 420-423.

LOSS OF EPIDERMAL LANGERHANS CELLS AND ENDOTHELIAL-CELL HLA-DR ANTIGENS IN THE SKIN IN PROGRESSIVE SYSTEMIC-SCLEROSIS
Andrews, B. S., FRIOU, G. J., Barr, R. J., Mirick, G. R., Berman, M., & Ross, P. A. (1986). LOSS OF EPIDERMAL LANGERHANS CELLS AND ENDOTHELIAL-CELL HLA-DR ANTIGENS IN THE SKIN IN PROGRESSIVE SYSTEMIC-SCLEROSIS. JOURNAL OF RHEUMATOLOGY, 13(2), 341-348.

STUDIES OF AN INTERLEUKIN-1 INHIBITOR - CHARACTERIZATION AND CLINICAL-SIGNIFICANCE
Berman, M. A., Sandborg, C. I., CALABIA, B. S., Andrews, B. S., & FRIOU, G. J. (1986). STUDIES OF AN INTERLEUKIN-1 INHIBITOR - CHARACTERIZATION AND CLINICAL-SIGNIFICANCE. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 64(1), 136-145.

INTERLEUKIN-1 PRODUCTION BY MONONUCLEAR-CELLS FROM PATIENTS WITH SCLERODERMA
Sandborg, C. I., Berman, M. A., Andrews, B. S., & FRIOU, G. J. (1985). INTERLEUKIN-1 PRODUCTION BY MONONUCLEAR-CELLS FROM PATIENTS WITH SCLERODERMA. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 60(2), 294-302.

SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES
Buckingham, B. A., UITTO, J., Sandborg, C., Keens, T., Roe, T., & Castellano, A. (1984). SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES. DIABETES CARE, 7(2), 163-169.

NEONATAL HYPER-NATREMIA ASSOCIATED WITH ELEVATED SODIUM CONCENTRATION OF BREAST-MILK
Anand, S. K., Sandborg, C., Robinson, R. G., & Lieberman, E. (1980). NEONATAL HYPER-NATREMIA ASSOCIATED WITH ELEVATED SODIUM CONCENTRATION OF BREAST-MILK. JOURNAL OF PEDIATRICS, 96(1), 66-68.

COMPETITION FOR HOST ESSENTIAL AND NONESSENTIAL FATTY-ACIDS BY EHRLICH ASCITES-CARCINOMA IN MICE
Baker, N., Sandborg, C., Morris, D., & Ookhtens, M. (1977). COMPETITION FOR HOST ESSENTIAL AND NONESSENTIAL FATTY-ACIDS BY EHRLICH ASCITES-CARCINOMA IN MICE. CANCER RESEARCH, 37(7), 2218-2225.

BLOOD-SAMPLING TECHNIQUES FOR STUDYING RAPIDLY TURNING OVER METABOLIC FUELS IN MICE
Baker, N., Morris, D., & Sandborg, C. (1976). BLOOD-SAMPLING TECHNIQUES FOR STUDYING RAPIDLY TURNING OVER METABOLIC FUELS IN MICE. LIPIDS, 11(11), 818-820.